News | October 15, 2012

Loma Linda University Medical Center offers answers to three common misconceptions about proton therapy

Proton Therapy Radiation Therapy Luma Linda University Medical Center

October 15, 2012 — For many people the words “proton therapy” may conjure up images of some type of high-tech treatment from the future. But the future is now; and since its development more than two decades ago, proton therapy has become a safe, highly effective and well-regarded option for the treatment of many forms of cancer. Still myths about proton therapy treatment continue to exist.

Father and son team James Slater and Jerry Slater pioneered proton therapy at Loma Linda University Medical Center (LLUMC) 22 years ago, making it the world’s first hospital-based proton treatment center for cancer. “Two decades later proton therapy continues to be misunderstood by many,” said Slater, who today serves as chairman of LLUMC’s Proton Treatment & Research Center. “This is very unfortunate because understanding proton therapy is the first step toward maximizing the wonderful benefits it can bring.”

In an effort to clear up the confusion and set the record straight, LLUMC offers answers to three of the most common misconceptions about proton therapy treatment.

Myth #1: Proton therapy is still an experimental treatment. — Since LLUMC brought modern proton treatment for cancer into the mainstream in 1990, there have been countless studies and trials that have shown proton therapy to be the treatment of choice for many types of cancer. Far from experimental, proton treatment has been refined and, coupled with leading-edge technology, has become one of the best treatment options for doctors and patients. So much so that patients literally travel from around the world to visit a proton treatment center where their cancer can be effectively treated.

Myth #2: Proton therapy is only effective for adults with prostate cancer. — While prostate cancer was one of the initial uses for proton therapy, the pinpoint accuracy of the proton beam also makes it a highly effective form of treatment for many other types of tumors that are often considered difficult to treat with standard radiation therapies. These include tumors found in the head, neck, lung and breast. At the same time proton therapy remains a highly effective treatment for prostate cancer as the targeted proton beams spare surrounding healthy tissue and minimize the typical side effects from standard photon beam radiation including incontinence and impotence.

Myth #3: Proton therapy is not a good option for children. — Just the opposite as proton therapy has proven to be the preferred method of treatment for many types of children’s tumors. This is due to the fact that proton beams specifically target the exact area of the tumor, which reduces/eliminates the “peripheral” radiation that can extend into surrounding tissue through other types of treatment.

“Because children are more sensitive to radiation than adults, standard radiation treatment typically is avoided in children, specifically those who are under 3 years old, as it can affect their bone growth,” said Lilia N. Loredo, assistant professor of radiation oncology at LLUMC’s Proton Treatment & Research Center. “Proton beams literally pinpoint specific tumors, sparing surrounding unaffected bone and tissue, which makes it both an ideal and highly effective form of treatment for all types of pediatric tumors.”


Related Content

News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
News | Breast Imaging

February 22, 2024 — The FAST-Forward randomized trial from the UK found that ultrahypofractionated whole breast ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 22, 2024 — The National Institutes of Health has launched a clinical trials network to evaluate emerging ...

Time February 22, 2024
arrow
News | Radiation Oncology

February 14, 2024 — Accuray Incorporated announced that the team at Quebec’s Montérégie Integrated Cancer Center, part ...

Time February 14, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
Subscribe Now